神经炎症的进展
Advances in Neuroinflammation.
作者信息
Wang Junhui, Sun Jing, Wang Hongxing
机构信息
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Thyropathy Hospital, Sun Simiao Hospital, Beijing University of Chinese Medicine, Tongchuan 727000, China.
出版信息
Brain Sci. 2024 Sep 26;14(10):965. doi: 10.3390/brainsci14100965.
Abstract
Recent research in neuroscience has shown significant advancements in relation to neuroinflammation, especially its role in neurological diseases, including neurodegenerative diseases [...].
摘要
神经科学领域的最新研究表明，在神经炎症方面取得了重大进展，尤其是其在包括神经退行性疾病在内的神经系统疾病中的作用[...]。
相似文献
1
Advances in Neuroinflammation.神经炎症的进展
Brain Sci. 2024 Sep 26;14(10):965. doi: 10.3390/brainsci14100965.
2
Insights into the advances in therapeutic drugs for neuroinflammation-related diseases.神经炎症相关疾病治疗药物的进展洞察。
Int J Neurosci. 2024 Nov;134(11):1256-1281. doi: 10.1080/00207454.2023.2260088. Epub 2023 Sep 21.
3
Neuroinflammation in Neurodegenerative Disorders-a Review.神经退行性疾病中的神经炎症——综述。
Curr Neurol Neurosci Rep. 2017 Mar;17(3):25. doi: 10.1007/s11910-017-0733-2.
4
The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.脑内炎症中 ghrelin 与小胶质细胞的相互作用：肥胖与神经退行性疾病的相关影响。
Int J Mol Sci. 2022 Nov 3;23(21):13432. doi: 10.3390/ijms232113432.
5
Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration.神经炎症的机制及其在神经退行性变中的作用的最新进展。
Neurochem Int. 2018 Nov;120:13-20. doi: 10.1016/j.neuint.2018.07.003. Epub 2018 Jul 19.
6
Autophagy Modulators and Neuroinflammation.自噬调节剂与神经炎症
Curr Med Chem. 2020;27(6):955-982. doi: 10.2174/0929867325666181031144605.
7
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders.免疫调节性酰亚胺药物（IMiDs）在神经精神疾病和神经退行性疾病中的新用途
Front Neurosci. 2021 Mar 29;15:656921. doi: 10.3389/fnins.2021.656921. eCollection 2021.
8
Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases.西格玛-1受体调节的神经炎症在神经疾病中的作用
Front Cell Neurosci. 2018 Sep 20;12:314. doi: 10.3389/fncel.2018.00314. eCollection 2018.
9
Recent advances in preventing neurodegenerative diseases.预防神经退行性疾病的最新进展。
Fac Rev. 2021 Dec 1;10:81. doi: 10.12703/r/10-81. eCollection 2021.
10
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease.阿尔茨海默病中神经炎症与小胶质细胞相关性的认识进展
Immunotargets Ther. 2024 Jun 12;13:287-304. doi: 10.2147/ITT.S455881. eCollection 2024.
引用本文的文献
1
CCL4L2 is a potential biomarker for differentiating central and peripheral vertigo.CCL4L2是鉴别中枢性和周围性眩晕的一种潜在生物标志物。
Front Integr Neurosci. 2025 Jul 21;19:1620845. doi: 10.3389/fnint.2025.1620845. eCollection 2025.
本文引用的文献
1
Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders.慢性炎症性脱髓鞘性多发性神经病及相关疾病中初始轴突节段的病理学。
Int J Mol Sci. 2022 Nov 7;23(21):13621. doi: 10.3390/ijms232113621.
2
New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention.神经炎症在阿尔茨海默病发病机制中的新见解及其治疗干预的潜力。
Cells. 2022 Jun 14;11(12):1925. doi: 10.3390/cells11121925.
3
Immunotherapy for Glioblastoma: Current Progress and Challenges.胶质母细胞瘤的免疫治疗：现状与挑战。
Front Immunol. 2021 May 13;12:676301. doi: 10.3389/fimmu.2021.676301. eCollection 2021.
4
Plasma cholesterol in Alzheimer's disease and frontotemporal dementia.阿尔茨海默病和额颞叶痴呆中的血浆胆固醇
Transl Neurosci. 2020 May 18;11(1):116-123. doi: 10.1515/tnsci-2020-0098. eCollection 2020.
5
EGFR as a clinical marker in glioblastomas and other gliomas.表皮生长因子受体作为胶质母细胞瘤和其他胶质瘤的临床标志物。
Int J Biol Markers. 2018 Jan;33(1):22-32. doi: 10.5301/ijbm.5000301.
6
Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.载脂蛋白E基因多态性与阿尔茨海默病患者血脂及载脂蛋白水平的相关性
Neurosci Lett. 2006 Nov 6;408(1):68-72. doi: 10.1016/j.neulet.2006.08.048. Epub 2006 Sep 25.
7
Inflammation in neurodegenerative disease--a double-edged sword.神经退行性疾病中的炎症——一把双刃剑。
Neuron. 2002 Aug 1;35(3):419-32. doi: 10.1016/s0896-6273(02)00794-8.
Zotero 插件